A protein long known for protecting chromosome tips has been caught doing a second job: keeping muscle stem cells from turning into fat and scar tissue after injury. Researchers at the Perelman School of Medicine at the University of Pennsylvania have uncovered this unexpected side gig, which could point toward muscular dystrophy treatments and even shed light on cancer biology.

The study, published in Science Advances, reveals that TRF2 - traditionally a telomere shield - also preserves the genetic identity of muscle stem cells, allowing them to regenerate damaged muscle. "For years, TRF2 has been viewed as a protein whose primary job is protecting the ends of chromosomes from damage or corruption," said senior author Foteini Mourkioti, PhD, an associate professor of Orthopedic Surgery at Penn Medicine. "But rather than simply protecting DNA, TRF2 seems to be key to regenerating muscle throughout life."

In lab experiments, TRF2 levels rose and fell in a carefully timed dance as muscle stem cells cycled between resting, repairing, and renewing. When researchers removed TRF2 from muscle stem cells in mice, the cells didn't die - a twist that defied expectations - but they lost their molecular mojo. Instead of rebuilding healthy muscle after injury, the damaged areas filled with fat and scar tissue. "This completely changes how we think about TRF2's role in these cells," Mourkioti said. "The loss of identity has severe implications for whether recovery from injury is even possible."

The plot thickened when the team tested TRF2 removal in a mouse model of Duchenne muscular dystrophy. The disease accelerated, muscle deterioration worsened, and the mice died younger. The protein's secret? It doesn't just hang out at chromosome ends; it also binds to regulatory regions across the genome, many of which contain secondary DNA structures called G-quadruplexes - the same structures being eyed as cancer therapy targets.

"We found that TRF2 works through these secondary DNA structures to preserve the identity of muscle stem cells and keep them capable of repairing damaged muscle," Mourkioti said. "That was completely unexpected."

The discovery may help solve a biological riddle: skeletal muscle regenerates remarkably well, yet muscle cancers are rare. Understanding how muscle stem cells use TRF2 differently from other tissues could one day let researchers boost tissue repair without inviting cancer. Mourkioti and colleagues are now exploring whether this unusual TRF2 usage could lead to new muscular dystrophy treatments and insights into cancer biology.

The research was supported by grants from the National Institutes of Health/National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01 DK123356, R01s CA174904, GM101149, and FDN-143330), with materials provided by the University of Pennsylvania School of Medicine.